RUNX3 and neoplasm: Regarding neoangiogenesis, microvessel detection with CD31 staining indicated that suppression of RUNX3 expression in the tumor‐promoting fibroblasts affected the microvessel numbers significantly and reduced the microvessel‐occupied areas with two out of three shRNAs.